Delivery Order SPE2DB20D1051-SPE2DB24FD8VF

Award Date 7/30/24
Potential Completion Date 8/20/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,538.79, is for the delivery of the drug Tagrisso 80 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of June 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,047.10 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of TAGRISSO 80 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $21,016.64 firm fixed price delivery order is for the supply of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2024 and was awarded on July 11, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of the drug Tagrisso 80 mg tablets. The $10,538.79 firm fixed-price contract has a completion date of July 10, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $21,077.60 to the Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of Tagrisso 80 mg tablets, a prescription medication. This Delivery Order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $31,616.37 delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a prescription medication. The contract is a firm-fixed-price type and has an ultimate completion date of September 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $10,903.03 firm-fixed price contract is for the supply of 4566518732 TAGRISSO 80 MG TABLET 30S, with a period of performance through December 13, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $10,903.03, is for the supply of TAGRISSO 80 MG TABLET 30S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $10,538.79 for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The award is valued at $10,508.31 and has a firm fixed price. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its broader federal contracting activities with various defense...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB24FD8VF
    Delivery Order

This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,538.79 firm-fixed price contract is for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The ultimate completion date for this delivery order is August 20, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for providing a wide range of medical commodities to support military treatment programs and facilities worldwide. The company also has an IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for supplying medical products and prescription drugs. These IDCs enable efficient procurement of essential pharmaceutical and medical supplies by various government agencies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 10/29/24, 9:08 AM